The authors, Yongqi Zhang, Eric M. Yeatman and Ranan Dasgupta, frame the problem in terms of the two fundamentally different failure modes of the lower urinary tract. In detrusor underactivity, the bladder cannot contract strongly enough to void, so mechanical assistance is needed during emptying. In detrusor overactivity, by contrast, the bladder contracts aberrantly during the storage phase, producing urgency and incontinence, so the therapeutic goal is inhibition rather than assistance. A single soft-robotic construct, they argue, could in principle address both phenotypes — but only if its control logic is matched to the underlying physiology, and only if a series of formidable biomechanical and regulatory challenges can be overcome.

The core of the proposal is a soft actuator sleeve that conforms to the exterior of the bladder. Unlike traditional rigid implants, which create stress concentrations and can damage delicate tissue, soft actuators made from elastomers, pneumatics or magnetic materials distribute forces gently across the organ wall. The conceptual architecture involves sensing bladder volume and pressure in real time, deciding when assistance is appropriate, and then applying controlled compression to raise intravesical pressure and drive urine through the urethra. The authors describe an idealized pressure–flow relationship for voiding assistance, drawing on Laplace-law insights from ultrasound urodynamics: because wall tension depends on both pressure and radius, a compliant sleeve can amplify the effectiveness of modest actuation forces as the bladder empties and shrinks.

Crucially, the authors insist that voiding assistance must be strictly patient initiated — a human-in-the-loop control philosophy. Micturition is not merely a mechanical reflex; it is gated by supraspinal brain circuits that integrate social context, and functional brain imaging has shown that urgency and continence involve forebrain influences on the pontine micturition switch. An implant that squeezed the bladder autonomously whenever it detected fullness would override this behavioural gating and could cause socially catastrophic emptying. Preserving social continence therefore requires that the machine act only when the patient commands it, with the algorithm serving as an amplifier of intent rather than a replacement for it. Emerging brain–computer interface work decoding urination motor attempts in spinal cord injury patients suggests that even severely injured patients may retain the neural signals needed to trigger such systems.

The opposite phenotype demands the mirror-image strategy. For detrusor overactivity, the authors propose autonomous, closed-loop neuromodulation that detects and inhibits aberrant bladder micromotions during storage without any conscious patient intervention. Unregulated autonomous micromotions of the bladder wall have been implicated in both overactive bladder and detrusor underactivity, and animal studies have demonstrated that closed-loop stimulation triggered by the frequency spectrum of non-voiding bladder activity can suppress unwanted contractions. Recent advances in precise tibial nerve stimulation, guided by evoked compound action potential feedback, point toward implantable systems that could continuously monitor bladder electrical or mechanical signals and deliver inhibitory neuromodulation the moment pathological activity begins — a genuinely artificial continence reflex.

Three families of actuators are emerging as candidates for the mechanical side of the problem, each at a different level of technology readiness. Pneumatic artificial muscles, including PneuNet-type bending actuators, offer high forces and simple fabrication but require pneumatic lines or pumps that complicate implantation. Dielectric elastomer actuators, which squeeze a soft elastomer film between compliant electrodes at high voltage, deliver large strains and fast response, and recent multilayer designs have achieved impressive performance — yet they face dielectric breakdown risks and the challenge of generating kilovolt-level fields safely inside the body. Magnetic soft actuators, in which embedded magnetic particles allow an implant to be deformed by external fields, have already been used to build a magnetically controlled robotic bladder that enhanced urine flow in experimental work, and they eliminate the need for on-board power electronics at the cost of requiring an external field source.

Whatever the actuator technology, the authors identify a set of biomechanical constraints that any clinical system must solve. During the filling phase, a snugly fitted sleeve can create a suction effect that resists bladder expansion, so the design must incorporate fail-safe open mechanical architectures that relax passively as the organ fills. Long-term implantation inevitably provokes fibrotic encapsulation, the foreign-body response that thickens tissue interfaces and degrades both sensing fidelity and mechanical coupling. Power delivery is equally thorny: implantable batteries add volume and eventually require replacement, driving interest in wireless approaches ranging from ultra-low-frequency magnetic energy focusing to ultrasound and magnetoelectric transduction. Encapsulation films built on atomic-layer-deposited nanolaminates must keep body fluids out for years, and any magnetic components must satisfy MRI safety standards such as ISO/TS 10974 and the relevant ASTM test methods for heating, torque and displacement.

Sensing and computation, meanwhile, are advancing rapidly on the soft-electronics front. Fully implantable, sensorized artificial bladders have been demonstrated that monitor volume and fullness continuously, and wireless bioelectronic harnesses with soft strain sensors can track bladder function through surgical recovery. Stretchable sensors based on liquid metals, graphene, conductive hydrogels and high-linearity capacitive designs provide the raw signals, while in-sensor and near-sensor computing — the emerging discipline of tiny machine learning — allows classification of bladder states on milliwatt-scale edge processors rather than in the cloud. The authors point to benchmark suites such as MLPerf Tiny as evidence that the computational hardware needed for on-board, adaptive control is arriving just as the actuator hardware matures.

The final hurdles are ethical and regulatory rather than purely technical. Algorithmic continence control raises questions about autonomy, consent and failure modes: what happens when an adaptive machine learning system drifts, or is compromised? The authors note that regulatory pathways for adaptive artificial intelligence in bioelectronics are still being created — the US Food and Drug Administration has only recently finalized guidance on predetermined change control plans for AI-enabled device software and on cybersecurity in medical devices — and that a definitive roadmap must outline how continuously learning implants will be validated, updated and monitored over a lifetime of use. Sterilization standards, biocompatibility evaluation under ISO 10993 and radio-spectrum rules for medical implants further shape the engineering envelope.

None of these obstacles, the authors conclude, is fatal; each is the kind of problem that interdisciplinary collaboration between engineers, urologists and neuroscientists has solved before in adjacent fields, most visibly in soft robotic cardiac sleeves that restored pumping function in experimental hearts. If the field can integrate fail-safe mechanics, robust sensing, patient-centred control and trustworthy adaptive algorithms, soft-robotic bladder orthoses could transform the management of lower urinary tract dysfunction — replacing the catheter bag with an invisible, compliant machine that restores not just voiding, but the quiet, unremarkable social confidence that continence makes possible. For a condition that has seen so little therapeutic progress over the past few decades, that would be nothing short of revolutionary.

Subject of Research: Soft robotic bladder implants for restoring urinary voiding and continence control

Article Title: The potential of soft robotics for the restoration of urinary voiding

Article References: Zhang, Y., Yeatman, E. M., & Dasgupta, R. (2026). The potential of soft robotics for the restoration of urinary voiding. Nature Reviews Urology. https://doi.org/10.1038/s41585-026-01186-z

Image Credits: AI Generated

DOI: 10.1038/s41585-026-01186-z

Keywords: soft robotics, bladder, urinary retention, detrusor underactivity, detrusor overactivity, neuromodulation, bioelectronics, implantable devices, continence, dielectric elastomer actuators, closed-loop control, urology